Werewolf Therapeutics, Inc. (HOWL) › Shareholders' EquityWerewolf Therapeutics, Inc. (HOWL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$24.30M2020: -$51.86M2021: $152.79M2022: $122.34M2023: $111.37M2024: $73.39M2025: $24.80M$24.80M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$24.80M-66.2%2024$73.39M-34.1%2023$111.37M-9.0%2022$122.34M-19.9%2021$152.79M+394.6%2020-$51.86M-113.4%2019-$24.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share